Article · 27 Feb 2026
ArticlePublished 28 Jun 2024
Adverse Drug Reactions in Rheumatology: Understanding and Mitigating Risks
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Adverse drug reactions (ADRs) are a significant concern in the field of rheumatology, where patients often require long-term pharmacotherapy to manage chronic inflammatory conditions. Rheumatic diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and ankylosing spondylitis, are commonly treated with a variety of medications, including nonsteroidal antiinflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologics. While these therapies are effective in controlling disease activity and improving patient outcomes, they also carry a risk of ADRs, which can range from mild to severe and, in some cases, life-threatening. Understanding the nature of these reactions, their risk factors, and strategies for mitigation is essential for optimizing patient care in rheumatology.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Clinical Rheumatology.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Ahmad Nabil Youssef”